Recent Quarter Total Invested
$3.62 B
Recent Quarter Institutional Ownership Percentage
104.59%
Total Invested of Last Quarter
$3.69 B
Ownership Percentage of Last Quarter
97.47%
Ultragenyx Pharmaceutical Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 08/13/2024 | 9.78 M | $401.98 M | 12.42% | 11.60% |
BLACKROCK INC. | 08/13/2024 | 5.60 M | $230.30 M | 7.02% | 6.65% |
SANDS CAPITAL MANAGEMENT, LLC | 08/13/2024 | 5.35 M | $220.08 M | 38.74% | 6.35% |
WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 4.56 M | $187.26 M | 11.18% | 5.41% |
RTW INVESTMENTS, LP | 08/14/2024 | 3.26 M | $133.98 M | -54.00% | 3.87% |
PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 2.99 M | $122.97 M | -16.17% | 3.55% |
STATE STREET CORP | 08/14/2024 | 2.70 M | $110.85 M | -5.41% | 3.20% |
CLEARBRIDGE INVESTMENTS, LLC | 08/27/2024 | 2.35 M | $96.74 M | -1.96% | 2.79% |
ALKEON CAPITAL MANAGEMENT LLC | 08/14/2024 | 2.24 M | $92.14 M | 0.00% | 2.66% |
FEDERATED HERMES, INC. | 08/08/2024 | 2.11 M | $86.60 M | 8.68% | 2.50% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 08/14/2024 | 2.06 M | $84.72 M | 22.94% | 2.45% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2024 | 1.92 M | $79.08 M | 8.40% | 2.28% |
MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 1.85 M | $76.07 M | 161.44% | 2.20% |
VESTAL POINT CAPITAL, LP | 08/14/2024 | 1.80 M | $73.98 M | 1,536.36% | 2.14% |
DEUTSCHE BANK AG\ | 08/14/2024 | 1.78 M | $73.25 M | 47.64% | 2.11% |
ALLIANCEBERNSTEIN L.P. | 08/14/2024 | 1.53 M | $62.80 M | 3.06% | 1.81% |
GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.51 M | $61.89 M | 12.36% | 1.79% |
BAKER BROS. ADVISORS LP | 08/14/2024 | 1.47 M | $60.28 M | 0.00% | 1.74% |
INVESCO LTD. | 08/13/2024 | 1.27 M | $52.13 M | 152.22% | 1.50% |
MARSHALL WACE, LLP | 08/14/2024 | 1.13 M | $46.57 M | 16.94% | 1.34% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2024 | 1.13 M | $46.24 M | 650.00% | 1.33% |
NORGES BANK | 08/14/2024 | 1.00 M | $41.20 M | 100.00% | 1.19% |
FIRST LIGHT ASSET MANAGEMENT, LLC | 08/14/2024 | 963,146 | $39.59 M | 21.85% | 1.14% |
AVIDITY PARTNERS MANAGEMENT LP | 08/14/2024 | 960,000 | $39.46 M | 2.84% | 1.14% |
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 07/30/2024 | 830,375 | $34.13 M | 63.75% | 0.99% |
AVORO CAPITAL ADVISORS LLC | 08/14/2024 | 830,000 | $34.11 M | 0.00% | 0.98% |
BANK OF NEW YORK MELLON CORP | 07/25/2024 | 781,943 | $32.14 M | -14.23% | 0.93% |
SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2024 | 716,947 | $29.47 M | 62.65% | 0.85% |
CANDRIAM S.C.A. | 08/05/2024 | 688,942 | $28.31 M | 33.10% | 0.82% |
FMR LLC | 08/13/2024 | 647,618 | $26.62 M | -17.19% | 0.77% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 08/14/2024 | 634,327 | $26.07 M | -7.75% | 0.75% |
GOLDMAN SACHS GROUP INC | 08/13/2024 | 629,514 | $25.87 M | 72.89% | 0.75% |
MAN GROUP PLC | 08/14/2024 | 628,726 | $25.84 M | 309.22% | 0.75% |
TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 568,309 | $23.36 M | 36.84% | 0.67% |
PICTET ASSET MANAGEMENT HOLDING SA | 08/13/2024 | 556,818 | $22.89 M | -46.27% | 0.66% |
FRED ALGER MANAGEMENT, LLC | 08/14/2024 | 548,905 | $22.56 M | -5.61% | 0.65% |
BANK OF AMERICA CORP /DE/ | 08/14/2024 | 547,818 | $22.52 M | 27.24% | 0.65% |
POINT72 ASSET MANAGEMENT, L.P. | 09/16/2024 | 539,749 | $22.18 M | 786.29% | 0.64% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 537,616 | $22.10 M | 10.99% | 0.64% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 08/15/2024 | 528,180 | $21.71 M | 35.68% | 0.63% |
EAGLE HEALTH INVESTMENTS LP | 08/13/2024 | 524,500 | $21.56 M | 75.01% | 0.62% |
MORGAN STANLEY | 08/14/2024 | 497,969 | $20.47 M | -1.27% | 0.59% |
EMERALD ADVISERS, LLC | 08/06/2024 | 486,682 | $20.00 M | -0.30% | 0.58% |
TWO SIGMA ADVISERS, LP | 08/14/2024 | 442,200 | $18.17 M | -1.34% | 0.52% |
AXA S.A. | 08/14/2024 | 425,334 | $17.48 M | 27.82% | 0.50% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/15/2024 | 425,000 | $17.47 M | 100.00% | 0.50% |
HUDSON BAY CAPITAL MANAGEMENT LP | 08/14/2024 | 415,000 | $17.06 M | 36.02% | 0.49% |
GW&K INVESTMENT MANAGEMENT, LLC | 08/12/2024 | 406,519 | $16.71 M | 34.00% | 0.48% |
WALLEYE CAPITAL LLC | 08/14/2024 | 390,592 | $16.05 M | 46.49% | 0.46% |
EMERALD MUTUAL FUND ADVISERS TRUST | 08/06/2024 | 390,524 | $16.05 M | 1.35% | 0.46% |
Ultragenyx Pharmaceutical Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of RARE shares?
During the previous two years, 378 institutional investors and hedge funds held shares of Ultragenyx Pharmaceutical Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 9.78 M
BlackRock Inc.: 5.6 M
SANDS CAPITAL MANAGEMENT, LLC: 5.35 M
WELLINGTON MANAGEMENT GROUP LLP: 4.56 M
RTW INVESTMENTS, LP: 3.26 M
PRICE T ROWE ASSOCIATES INC /MD/: 2.99 M
-
What percentage of Ultragenyx Pharmaceutical Inc. stock is owned by institutional investors?
104.59% of Ultragenyx Pharmaceutical Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at RARE ?
Institutional investors have bought a total of 95.73 M shares in the last 24 months. This purchase volume represents approximately $5.14 B in transactions.